Taysha Gene Therapies Ownership | Who Owns Taysha Gene Therapies?
Taysha Gene Therapies Ownership Summary
Taysha Gene Therapies is owned by 86.45% institutional investors, 11.19% insiders, and 2.36% retail investors. Rtw investments, lp is the largest institutional shareholder, holding 8.40% of TSHA shares. Fidelity Growth Compy Commingled Pl O is the top mutual fund, with 3.16% of its assets in Taysha Gene Therapies shares.
TSHA Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Taysha Gene Therapies | 86.45% | 11.19% | 2.36% |
| Sector | Healthcare Stocks | 488.17% | 11.08% | -399.26% |
| Industry | Biotech Stocks | 306.59% | 11.10% | -217.69% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Rtw investments, lp | 25.02M | 8.40% | $57.80M |
| Ra capital management | 23.56M | 7.90% | $54.41M |
| Avoro capital advisors | 21.70M | 7.28% | $50.13M |
| Fmr | 16.37M | 6.11% | $28.31M |
| Blackrock | 11.74M | 5.08% | $26.30M |
| Blackrock funding, inc. /de | 13.30M | 4.46% | $30.73M |
| Siren | 11.01M | 3.70% | $25.44M |
| Jefferies financial group | 10.31M | 3.46% | $23.82M |
| Vanguard group | 8.91M | 3.33% | $15.41M |
| Morgan stanley | 7.48M | 3.23% | $16.75M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Tybourne capital management (hk) | 4.09M | 27.39% | $9.46M |
| Octagon capital advisors lp | 2.42M | 3.44% | $17.78M |
| Great point partners | 1.50M | 2.25% | $3.46M |
| Acuta capital partners | 485.67K | 1.57% | $1.12M |
| Siren | 11.01M | 1.32% | $25.44M |
| Bioimpact capital | 2.95M | 1.18% | $6.82M |
| Adar1 capital management | 3.01M | 1.07% | $6.95M |
| Ra capital management | 23.56M | 0.92% | $54.41M |
| Stempoint capital lp | 1.20M | 0.89% | $2.78M |
| Avoro capital advisors | 21.70M | 0.88% | $50.13M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Ra capital management | 23.56M | 0.92% | 12.68M |
| Jefferies financial group | 10.31M | 0.20% | 10.07M |
| Blackrock | 11.74M | 0.00% | 9.15M |
| Rtw investments, lp | 25.02M | 0.82% | 6.23M |
| Deerfield management company, l.p. (series c) | 5.39M | 0.23% | 5.39M |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Octagon capital advisors lp | 2.42M | 3.44% | -8.03M |
| Vr adviser | - | - | -3.23M |
| Deutsche bank ag\ | 151.08K | 0.00% | -2.41M |
| Eversept partners, lp | - | - | -2.33M |
| Fmr | 16.37M | 0.00% | -2.31M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Deerfield management company, l.p. (series c) | 5.39M | 0.23% | 5.39M | $12.44M |
| Toronto dominion bank | 4.73M | 0.02% | 4.73M | $10.92M |
| Suvretta capital management | 3.22M | 0.22% | 3.22M | $7.43M |
| Vestal point capital, lp | 3.00M | 0.36% | 3.00M | $6.93M |
| Bioimpact capital | 2.95M | 1.18% | 2.95M | $6.82M |
Sold Out
| Holder | Change |
|---|---|
| Quadrant capital group | -2.00 |
| Riggs asset managment | -198.00 |
| Coldstream capital management | -207.00 |
| Corecap advisors | -290.00 |
| Clear street markets | -424.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2025 | 148 | 16.54% | 257,619,957 | 54.48% | 86 | 2.25% | 90 | 45.16% | 33 | 10.00% |
| Mar 31, 2025 | 12 | -90.63% | 63,845,739 | -61.79% | 25 | 0.66% | 7 | -90.41% | 1 | -96.00% |
| Dec 31, 2024 | 126 | 5.00% | 167,074,710 | 6.47% | 62 | 1.82% | 72 | -4.00% | 25 | 56.25% |
| Sep 30, 2024 | 120 | 12.15% | 156,916,875 | -0.74% | 58 | 1.25% | 75 | 15.38% | 16 | -11.11% |
| Jun 30, 2024 | 107 | -3.60% | 158,086,768 | 12.80% | 68 | 1.86% | 65 | -1.52% | 18 | -28.00% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Fidelity Growth Compy Commingled Pl O | 6.48M | 3.16% | - |
| Vanguard Total Stock Mkt Idx Inv | 6.63M | 2.43% | -147.09K |
| Vanguard US Total Market Shares ETF | 4.46M | 2.17% | - |
| Fidelity Growth Compy Commingled Pl S | 5.36M | 2.05% | 6.78K |
| Polar Capital Biotech S Inc | 5.00M | 1.83% | - |
| Fidelity Growth Company Fund | 4.23M | 1.62% | - |
| iShares Russell 2000 ETF | 3.94M | 1.51% | -74.86K |
| Fidelity Select Biotechnology | 3.51M | 1.34% | -292.30K |
| Xtrackers MSCI World Swap ETF 1C | 2.47M | 1.20% | - |
| Fidelity Small Cap Index | 1.78M | 0.68% | -4.69K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Aug 21, 2025 | Nagendran Sukumar | President and Head of R&D | Sell | $162.60K |
| Aug 21, 2025 | Alam Kamran | CHIEF FINANCIAL OFFICER | Sell | $155.30K |
| May 30, 2025 | Manning Paul B | - | Buy | $2.06M |
| Jun 27, 2024 | Manning Paul B | - | Buy | $3.00M |
| Nov 17, 2023 | Manning Paul B | - | Buy | $163.00K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q3 | - | 2 |
| 2025 Q2 | 1 | - |
| 2025 Q1 | - | - |
| 2024 Q2 | 1 | - |
| 2024 Q1 | - | - |
TSHA Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools